These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18055823)

  • 1. The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits.
    Ameri H; Chader GJ; Kim JG; Sadda SR; Rao NA; Humayun MS
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5708-15. PubMed ID: 18055823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
    Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
    Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescein angiography, optical coherence tomography, and histopathologic findings in a VEGF(165) animal model of retinal angiogenesis.
    Arana LA; Pinto AT; Chader GJ; Barbosa JD; Morales S; Moreira AT; Maia M; Humayun MS
    Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1421-8. PubMed ID: 22427240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbits.
    Saati S; Agrawal RN; Louie S; Chader GJ; Humayun MS
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):457-66. PubMed ID: 19644699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation.
    Ghazi NG; Knape RM; Kirk TQ; Tiedeman JS; Conway BP
    Retina; 2008 May; 28(5):689-95. PubMed ID: 18463511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
    Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
    Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Holz FG; Scholl HP
    Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subretinal bevacizumab detection after intravitreous injection in rabbits.
    Dib E; Maia M; Longo-Maugeri IM; Martins MC; Mussalem JS; Squaiella CC; Penha FM; Magalhães O; Rodrigues EB; Farah ME
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1097-100. PubMed ID: 18326736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab.
    Kumar A; Sinha S
    Can J Ophthalmol; 2007 Apr; 42(2):335-6. PubMed ID: 17392871
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal bevacizumab in inflammatory ocular neovascularization.
    Mansour AM; Mackensen F; Arevalo JF; Ziemssen F; Mahendradas P; Mehio-Sibai A; Hrisomalos N; Lai TY; Dodwell D; Chan WM; Ness T; Banker AS; Pai SA; Berrocal MH; Tohme R; Heiligenhaus A; Bashshur ZF; Khairallah M; Salem KM; Hrisomalos FN; Wood MH; Heriot W; Adan A; Kumar A; Lim L; Hall A; Becker M
    Am J Ophthalmol; 2008 Sep; 146(3):410-416. PubMed ID: 18619571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
    Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
    Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin).
    Isaacs TW; Barry C
    Clin Exp Ophthalmol; 2006 Nov; 34(8):802-3. PubMed ID: 17073910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
    Spandau UH; Jonas JB
    Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study.
    Bonini-Filho M; Costa RA; Calucci D; Jorge R; Melo LA; Scott IU
    Am J Ophthalmol; 2009 Jun; 147(6):1022-30, 1030.e1-5. PubMed ID: 19327746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
    Kovach JL; Rosenfeld PJ
    Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy.
    Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
    J AAPOS; 2014 Apr; 18(2):120-3. PubMed ID: 24698606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy.
    Siqueira RC; Costa RA; Scott IU; Cintra LP; Jorge R
    Acta Ophthalmol Scand; 2006 Dec; 84(6):834-5. PubMed ID: 17083555
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results.
    Gharbiya M; Allievi F; Recupero V; Martini D; Mazzeo L; Gabrieli CB
    Retina; 2009 Jun; 29(6):740-9. PubMed ID: 19516116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.